Regencell Bioscience Holdings Stock Price, News & Analysis
RGC
NASDAQ
Company Description
Welcome to the overview page for Regencell Bioscience Holdings (RGC), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
Latest News
SEC Filings
Financial Highlights
$3,163,000,000
Revenue (TTM)
$112,300,000
Net Income (TTM)
$0.72
$409,900,000
Operating Cash Flow
3.55%
8.59%
Upcoming Events
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Regencell Bioscience Holdings (RGC)?
The current stock price of Regencell Bioscience Holdings (RGC) is $14.58 as of September 24, 2025.
What is the market cap of Regencell Bioscience Holdings (RGC)?
The market cap of Regencell Bioscience Holdings (RGC) is approximately 7.3B. Learn more about what market capitalization means.
What is the revenue (TTM) of Regencell Bioscience Holdings (RGC) stock?
The trailing twelve months (TTM) revenue of Regencell Bioscience Holdings (RGC) is $3,163,000,000.
What is the net income of Regencell Bioscience Holdings (RGC)?
The trailing twelve months (TTM) net income of Regencell Bioscience Holdings (RGC) is $112,300,000.
What is the earnings per share (EPS) of Regencell Bioscience Holdings (RGC)?
The diluted earnings per share (EPS) of Regencell Bioscience Holdings (RGC) is $0.72 on a trailing twelve months (TTM) basis. Learn more about EPS.
What is the operating cash flow of Regencell Bioscience Holdings (RGC)?
The operating cash flow of Regencell Bioscience Holdings (RGC) is $409,900,000. Learn about cash flow.
What is the profit margin of Regencell Bioscience Holdings (RGC)?
The net profit margin of Regencell Bioscience Holdings (RGC) is 3.55%. Learn about profit margins.
What is the operating margin of Regencell Bioscience Holdings (RGC)?
The operating profit margin of Regencell Bioscience Holdings (RGC) is 8.59%. Learn about operating margins.
What is the current ratio of Regencell Bioscience Holdings (RGC)?
The current ratio of Regencell Bioscience Holdings (RGC) is 0.83, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Regencell Bioscience Holdings (RGC)?
The operating income of Regencell Bioscience Holdings (RGC) is $271,700,000. Learn about operating income.